13 May، 2025

obesity

FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity إدارة الغذاء والدواء الأميركية تعتمد الدواء الأول والوحيد لانقطاع التنفس الانسدادي أثناء النوم لدى البالغين المصابين بالسمنة

FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity

manager 16 January، 2025
Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions...
Read More Read more about FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity

You may have missed

Eastnets Double Award Win at 2025 MEA Finance Banking Technology Awards

Eastnets Double Award Win at 2025 MEA Finance Banking Technology Awards

Karren Franco 13 May، 2025
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner

Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner

Karren Franco 13 May، 2025
مطعم وصالة OVO: ملاذ دبي الجديد للمأكولات والترفيه

OVO Resto Lounge: Dubai’s New Gastronomic and Entertainment Haven

manager 13 May، 2025
Pearson Redefines its Brand to Embrace the Future of Learning

Pearson Redefines its Brand to Embrace the Future of Learning

NewsVoir 13 May، 2025